Should vitamin B12 status be considered in assessing risk of neural tube defects?

Annals of the New York Academy of Sciences

Volumn 1414, Issue 1, 2018, Pages 109-125

  Molloy, Anne M ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

cobalamin; folate; folic acid; maternal blood; vitamin B12

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID;

ARTICLE; CLINICAL TRIAL; CYANOCOBALAMIN DEFICIENCY; HEREDITY; HUMAN; MIDDLE INCOME COUNTRY; NEURAL TUBE DEFECT; RISK ASSESSMENT; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

EID: 85041106802     PISSN: 00778923     EISSN: 17496632     Source Type: Journal    
DOI: 10.1111/nyas.13574     Document Type: Article

References (142)

1. Blencowe, H., S. Cousens, B. Modell, et al. 2010. Folic acid to reduce neonatal mortality from neural tube disorders. Int. J. Epidemiol. 39(Suppl. 1): i110–i121.
2. Matthews, R.G. 1999. Cobalamin-dependent methionine synthase. In Chemistry and Biochemistry of B12. R. Banerjee, Ed.: 681–706. New York: John Wiley & Sons, Inc.
3. Rochtus, A., B. Izzi, E. Vangeel, et al. 2015. DNA methylation analysis of Homeobox genes implicates HOXB7 hypomethylation as risk factor for neural tube defects. Epigenetics 10: 92–101.
4. Hu, N., P.H. Strobl-Mazzulla & M.E. Bronner. 2014. Epigenetic regulation in neural crest development. Dev. Biol. 396: 159–168.
5. Molloy, A.M., F. Pangilinan & L.C. Brody. 2017. Genetic risk factors for folate-responsive neural tube defects. Ann. Rev. Nutr. 37: 269–291.
6. Scott, J.M. & D.G. Weir. 1981. The methyl folate trap. A physiological response in man to prevent methyl group deficiency in kwashiorkor (methionine deficiency) and an explanation for folic-acid induced exacerbation of subacute combined degeneration in pernicious anaemia. Lancet 2: 337–340.
7. Smithells, R.W., S. Sheppard & C.J. Schorah. 1976. Vitamin deficiencies and neural tube defects. Arch. Dis. Child. 51: 944–950.
8. Smithells, R.W., N.C. Nevin, M.J. Seller, et al. 1983. Further experience of vitamin supplementation for prevention of neural tube defect recurrences. Lancet 1: 1027–1031.
9. Schorah, C.J., J. Wild, R. Hartley, et al. 1983. The effect of periconceptional supplementation on blood vitamin concentrations in women at recurrence risk for neural tube defect. Br. J. Nutr. 49: 203–211.
10. MRC Vitamin Study Research Group. 1991. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 338: 131–137.
11. Molloy, A.M., P.N. Kirke, L.C. Brody, et al. 2008. Effects of folate and vitamin B12 deficiencies during pregnancy on fetal, infant, and child development. Food Nutr. Bull. 29(2 Suppl.): S101–S111; discussion S112–S115.
12. Allen, L.H. 2009. How common is vitamin B-12 deficiency? Am. J. Clin. Nutr. 89: 693s–696s.
13. Schorah, C.J., R.W. Smithells & J. Scott. 1980. Vitamin B12 and anencephaly. Lancet 1: 880.
14. Suarez, L., K. Hendricks, M. Felkner, et al. 2003. Maternal serum B12 levels and risk for neural tube defects in a Texas–Mexico border population. Ann. Epidemiol. 13: 81–88.
15. Wright, M.E. 1995. A case–control study of maternal nutrition and neural tube defects in Northern Ireland. Midwifery 11: 146–152.
16. Gaber, K.R., M.K. Farag, S.E. Soliman, et al. 2007. Maternal vitamin B12 and the risk of fetal neural tube defects in Egyptian patients. Clin. Lab. 53: 69–75.
17. Steegers-Theunissen, R.P., G.H. Boers, F.J. Trijbels, et al. 1994. Maternal hyperhomocysteinemia: a risk factor for neural-tube defects? Metabolism 43: 1475–1480.
18. Yates, J.R., M.A. Ferguson-Smith, A. Shenkin, et al. 1987. Is disordered folate metabolism the basis for the genetic predisposition to neural tube defects? Clin. Genet. 31: 279–287.
19. Afman, L.A., N.M. Van Der Put, C.M. Thomas, et al. 2001. Reduced vitamin B12 binding by transcobalamin II increases the risk of neural tube defects. QJM 94: 159–166.
20. Wild, J., C.J. Schorah, T.A. Sheldon, et al. 1993. Investigation of factors influencing folate status in women who have had a neural tube defect-affected infant. Br. J. Obstet. Gynecol. 100: 546–549.
21. Wilson, A., R. Platt, Q. Wu, et al. 1999. A common variant in methionine synthase reductase combined with low cobalamin (vitamin B12) increases risk for spina bifida. Mol. Genet. Metab. 67: 317–323.
22. van der Put, N.M., C.M. Thomas, T.K. Eskes, et al. 1997. Altered folate and vitamin B12 metabolism in families with spina bifida offspring. QJM 90: 505–510.
23. Steegers-Theunissen, R.P., G.H. Boers, F.J. Trijbels, et al. 1991. Neural-tube defects and derangement of homocysteine metabolism. N. Engl. J. Med. 324: 199–200.
24. Molloy, A.M., P. Kirke, I. Hillary, et al. 1985. Maternal serum folate and vitamin-B12 concentrations in pregnancies associated with neural-tube defects. Arch. Dis.Child. 60: 660–665.
25. Wald, N.J., A.D. Hackshaw, R. Stone, et al. 1996. Blood folic acid and vitamin B12 in relation to neural tube defects. Br. J. Obstet. Gynecol. 103: 319–324.
26. Steegers-Theunissen, R.P., G.H. Boers, H.J. Blom, et al. 1995. Neural tube defects and elevated homocysteine levels in amniotic fluid. Am. J. Obstet. Gynecol. 172: 1436–1441.
27. Adams, M.J., Jr., M.J. Khoury, K.S. Scanlon, et al. 1995. Elevated midtrimester serum methylmalonic acid levels as a risk factor for neural tube defects. Teratology 51: 311–317.
28. Mills, J.L., J.M. McPartlin, P.N. Kirke, et al. 1995. Homocysteine metabolism in pregnancies complicated by neural-tube defects. Lancet 345: 149–151.
29. Gardiki-Kouidou, P. & M.J. Seller. 1988. Amniotic fluid folate, vitamin B12 and transcobalamins in neural tube defects. Clin. Genet. 33: 441–448.
30. Dawson, E.B., D.R. Evans & J.W. Van Hook. 1998. Amniotic fluid B12 and folate levels associated with neural tube defects. Am. J. Perinatol. 15: 511–514.
31. Steen, M.T., A.M. Boddie, A.J. Fisher, et al. 1998. Neural-tube defects are associated with low concentrations of cobalamin (vitamin B12) in amniotic fluid. Prenat. Diagn. 18: 545–555.
32. Weekes, E.W., T. Tamura, R.O. Davis, et al. 1992. Nutrient levels in amniotic fluid from women with normal and neural tube defect pregnancies. Biol. Neonate 61: 226–231.
33. Economides, D.L., J. Ferguson, I.Z. Mackenzie, et al. 1992. Folate and vitamin B12 concentrations in maternal and fetal blood, and amniotic fluid in second trimester pregnancies complicated by neural tube defects. Br. J. Obstet. Gynecol. 99: 23–25.
34. Mills, J.L., J. Tuomilehto, K.F. Yu, et al. 1992. Maternal vitamin levels during pregnancies producing infants with neural tube defects. J. Pediatr. 120: 863–871.
35. Molloy, A.M., P.N. Kirke, J.F. Troendle, et al. 2009. Maternal vitamin B12 status and risk of neural tube defects in a population with high neural tube defect prevalence and no folic acid fortification. Pediatrics 123: 917–923.
36. Zhang, T., R. Xin, X. Gu, et al. 2009. Maternal serum vitamin B12, folate and homocysteine and the risk of neural tube defects in the offspring in a high-risk area of China. Public Health Nutr. 12: 680–686.
37. Ray, J.G., P.R. Wyatt, M.D. Thompson, et al. 2007. Vitamin B12 and the risk of neural tube defects in a folic-acid-fortified population. Epidemiology 18: 362–366.
38. Nasri, K., M.K. Ben Fradj, A. Touati, et al. 2015. Association of maternal homocysteine and vitamins status with the risk of neural tube defects in Tunisia: a case–control study. Birth Defects Res. A Clin. Mol. Teratol. 103: 1011–1020.
39. Tang, K.F., Y.L. Li & H.Y. Wang. 2015. Quantitative assessment of maternal biomarkers related to one-carbon metabolism and neural tube defects. Sci. Rep. 5: 8510.
40. Peker, E., N. Demir, O. Tuncer, et al. 2016. The levels of vitamin B12, folate and homocysteine in mothers and their babies with neural tube defects. J. Matern. Fetal Neonatal Med. 29: 2944–2948.
41. Czeizel, A.E. & I. Dudas. 1992. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N. Engl. J. Med. 327: 1832–1835.
42. Molloy, A.M., L.C. Brody, J.L. Mills, et al. 2009. The search for genetic polymorphisms in the homocysteine/folate pathway that contribute to the etiology of human neural tube defects. Birth Defects Res. A Clin. Mol. Teratol. 85: 285–294.
43. Amorim, M.R., M.A. Lima, E.E. Castilla, et al. 2007. Non-Latin European descent could be a requirement for association of NTDs and MTHFR variant 677C >T: a meta-analysis. Am. J. Med. Genet. A 143A: 1726–1732.
44. Shields, D.C., P.N. Kirke, J.L. Mills, et al. 1999. The “thermolabile” variant of methylenetetrahydrofolate reductase and neural tube defects: an evaluation of genetic risk and the relative importance of the genotypes of the embryo and the mother. Am. J. Hum. Genet. 64: 1045–1055.
45. Boyles, A.L., A.V. Billups, K.L. Deak, et al. 2006. Neural tube defects and folate pathway genes: family-based association tests of gene–gene and gene–environment interactions. Environ. Health Perspect. 114: 1547–1552.
46. Pangilinan, F., D. Swanson, A. Weiler, et al. 2003. Transcobalamin II polymorphisms influence plasma levels of vitamin B12 but are not major risk factors for neural tube defects. Am. J. Hum. Genet. 73: 525–525.
47. Candito, M., R. Rivet, B. Herbeth, et al. 2008. Nutritional and genetic determinants of vitamin B and homocysteine metabolisms in neural tube defects: a multicenter case–control study. Am. J. Med. Genet. A 146A: 1128–1133.
48. Pangilinan, F., A.M. Molloy, J.L. Mills, et al. 2014. Replication and exploratory analysis of 24 candidate risk polymorphisms for neural tube defects. BMC Med. Genet. 15: 102.
49. Winkels, R.M., I.A. Brouwer, R. Clarke, et al. 2008. Bread cofortified with folic acid and vitamin B-12 improves the folate and vitamin B-12 status of healthy older people: a randomized controlled trial. Am. J. Clin. Nutr. 88: 348–355.
50. Swanson, D.A., F. Pangilinan, J.L. Mills, et al. 2005. Evaluation of transcobalamin II polymorphisms as neural tube defect risk factors in an Irish population. Birth Defects Res. A Clin. Mol. Teratol. 73: 239–244.
51. Afman, L.A., K.J. Lievers, N.M. van der Put, et al. 2002. Single nucleotide polymorphisms in the transcobalamin gene: relationship with transcobalamin concentrations and risk for neural tube defects. Eur. J. Hum. Genet. 10: 433–438.
52. Pangilinan, F., A.M. Molloy, J.L. Mills, et al. 2012. Evaluation of common genetic variants in 82 candidate genes as risk factors for neural tube defects. BMC Med. Genet. 13: 62.
53. Pangilinan, F., A. Mitchell, J. VanderMeer, et al. 2010. Transcobalamin II receptor polymorphisms are associated with increased risk for neural tube defects. J. Med. Genet. 47: 677–685.
54. Kirke, P.N., A.M. Molloy, L.E. Daly, et al. 1993. Maternal plasma folate and vitamin B12 are independent risk factors for neural tube defects. Q. J. Med. 86: 703–708.
55. Afman, L.A., K.J. Lievers, L.A. Kluijtmans, et al. 2003. Gene–gene interaction between the cystathionine beta-synthase 31 base pair variable number of tandem repeats and the methylenetetrahydrofolate reductase 677C >T polymorphism on homocysteine levels and risk for neural tube defects. Mol. Genet. Metab. 78: 211–215.
56. Bjorke-Monsen, A.L., P.M. Ueland, J. Schneede, et al. 1997. Elevated plasma total homocysteine and C677T mutation of the methylenetetrahydrofolate reductase gene in patients with spina bifida. QJM 90: 593–596.
57. Daly, L.E., P.N. Kirke, A. Molloy, et al. 1995. Folate levels and neural tube defects. Implications for prevention. JAMA 274: 1698–1702.
58. Crider, K.S., O. Devine, L. Hao, et al. 2014. Population red blood cell folate concentrations for prevention of neural tube defects: Bayesian model. BMJ 349: g4554.
59. Rosenthal, J., N. Largaespada, L.B. Bailey, et al. 2017. Folate deficiency is prevalent in women of childbearing age in Belize and is negatively affected by coexisting vitamin B-12 deficiency: Belize National Micronutrient Survey 2011. J. Nutr. 147: 1183–1193.
60. Bailey, R.L., R.A. Durazo-Arvizu, R. Carmel, et al. 2013. Modeling a methylmalonic acid-derived change point for serum vitamin B-12 for adults in NHANES. Am. J. Clin. Nutr. 98: 460–467.
61. Metz, J. 2013. Haematological implications of folate food fortification. S. Afr. Med. J. 103: 978–981.
62. Hazra, A., P. Kraft, J. Selhub, et al. 2008. Common variants of FUT2 are associated with plasma vitamin B12 levels. Nat. Genet. 40: 1160–1162.
63. Tanaka, T., P. Scheet, B. Giusti, et al. 2009. Genome-wide association study of vitamin B6, vitamin B12, folate, and homocysteine blood concentrations. Am. J. Hum. Genet. 84: 477–482.
64. Murphy, M.M., A.M. Molloy, P.M. Ueland, et al. 2007. Longitudinal study of the effect of pregnancy on maternal and fetal cobalamin status in healthy women and their offspring. J. Nutr. 137: 1863–1867.
65. Green, R., L.H. Allen, A.L. Bjorke-Monsen, et al. 2017. Vitamin B12 deficiency. Nat. Rev. Dis. Primers 3: 17040.
66. Benson, J., C. Phillips, M. Kay, et al. 2013. Low vitamin B12 levels among newly-arrived refugees from Bhutan, Iran and Afghanistan: a multicentre Australian study. PLoS One 8: e57998.
67. Calis, J.C., K.S. Phiri, E.B. Faragher, et al. 2008. Severe anemia in Malawian children. N. Engl. J. Med. 358: 888–899.
68. Dang, S., H. Yan, L. Zeng, et al. 2014. The status of vitamin B12 and folate among Chinese women: a population-based cross-sectional study in northwest China. PLoS One 9: e112586.
69. Margo, G., Y. Baroni, G. Wells, et al. 1978. Protein energy malnutrition and nutritional anaemia in preschool children in rural KwaZulu. S. Afr. Med. J. 53: 21–26.
70. McLean, E., B. de Benoist & L.H. Allen. 2008. Review of the magnitude of folate and vitamin B12 deficiencies worldwide. Food Nutr. Bull. 29: S38–S51.
71. Pawlak, R., S.E. Lester & T. Babatunde. 2014. The prevalence of cobalamin deficiency among vegetarians assessed by serum vitamin B12: a review of literature. Eur. J. Clin. Nutr. 68: 541–548.
72. Yetley, E.A., C.M. Pfeiffer, K.W. Phinney, et al. 2011. Biomarkers of vitamin B-12 status in NHANES: a roundtable summary. Am. J. Clin. Nutr. 94: 313S–321S.
73. Sobczyńska-Malefora, A., R. Gorska, M. Pelisser, et al. 2014. An audit of holotranscobalamin (“Active” B 12) and methylmalonic acid assays for the assessment of vitamin B 12 status: application in a mixed patient population. Clin. Biochem. 47: 82–86.
74. Allen, L.H., J.L. Rosado, J.E. Casterline, et al. 1995. Vitamin B-12 deficiency and malabsorption are highly prevalent in rural Mexican communities. Am. J. Clin. Nutr. 62: 1013–1019.
75. Bailey, R.L., R. Carmel, R. Green, et al. 2011. Monitoring of vitamin B-12 nutritional status in the United States by using plasma methylmalonic acid and serum vitamin B-12. Am. J. Clin. Nutr. 94: 552–561.
76. Refsum, H., C.S. Yajnik, M. Gadkari, et al. 2001. Hyperhomocysteinemia and elevated methylmalonic acid indicate a high prevalence of cobalamin deficiency in Asian Indians. Am. J. Clin. Nutr. 74: 233–241.
77. Bondevik, G.T., J. Schneede, H. Refsum, et al. 2001. Homocysteine and methylmalonic acid levels in pregnant Nepali women. Should cobalamin supplementation be considered? Eur. J. Clin. Nutr. 55: 856–864.
78. Fedosov, S.N., A. Brito, J.W. Miller, et al. 2015. Combined indicator of vitamin B12 status: modification for missing biomarkers and folate status and recommendations for revised cut-points. Clin. Chem. Lab. Med. 53: 1215–1225.
79. Valente, E., J.M. Scott, P.M. Ueland, et al. 2011. Diagnostic accuracy of holotranscobalamin, methylmalonic acid, serum cobalamin, and other indicators of tissue vitamin B-12 status in the elderly. Clin. Chem. 57: 856–863.
80. van der Westhuyzen, J., S.V. van Tonder, I. Gilbertson, et al. 1986. Iron, folate and vitamin B12 nutrition and anaemia in black preschool children in the northern Transvaal. S. Afr. Med. J. 70: 143–146.
81. Bhardwaj, A., D. Kumar, S.K. Raina, et al. 2013. Rapid assessment for coexistence of vitamin B12 and iron deficiency anemia among adolescent males and females in northern Himalayan state of India. Anemia 2013: 959605.
82. Pathak, P., U. Kapil, C.S. Yajnik, et al. 2007. Iron, folate, and vitamin B12 stores among pregnant women in a rural area of Haryana state, India. Food Nutr. Bull. 28: 435–438.
83. Devalia, V., M.S. Hamilton & A.M. Molloy. 2014. Guidelines for the diagnosis and treatment of cobalamin and folate disorders. Br. J. Haematol. 166: 496–513.
84. Carmel, R. & M. Sarrai. 2006. Diagnosis and management of clinical and subclinical cobalamin deficiency: advances and controversies. Curr. Hematol. Rep. 5: 23–33.
85. Carmel, R. 2013. Diagnosis and management of clinical and subclinical cobalamin deficiencies: why controversies persist in the age of sensitive metabolic testing. Biochimie 95: 1047–1055.
86. Monsen, A.L., H. Refsum, T. Markestad, et al. 2003. Cobalamin status and its biochemical markers methylmalonic acid and homocysteine in different age groups from 4 days to 19 years. Clin. Chem. 49: 2067–2075.
87. Ray, J.G., J. Goodman, P.R. O'Mahoney, et al. 2008. High rate of maternal vitamin B12 deficiency nearly a decade after Canadian folic acid flour fortification. QJM 101: 475–477.
88. Hopkins, S.M., M.J. Gibney, A.P. Nugent, et al. 2015. Impact of voluntary fortification and supplement use on dietary intakes and biomarker status of folate and vitamin B-12 in Irish adults. Am. J. Clin. Nutr. 101: 1163–1172.
89. Brito, A., M.F. Mujica-Coopman, D. Lopez de Romana, et al. 2015. Folate and vitamin B12 status in Latin America and the Caribbean: an update. Food Nutr. Bull. 36: S109–S118.
90. Garcia-Casal, M.N., C. Osorio, M. Landaeta, et al. 2005. High prevalence of folic acid and vitamin B12 deficiencies in infants, children, adolescents and pregnant women in Venezuela. Eur. J. Clin. Nutr. 59: 1064–1070.
91. Centers for Disease Control and Prevention. 2011. Vitamin B12 deficiency in resettled Bhutanese refugees—United States, 2008–2011. MMWR Morb. Mortal. Wkly. Rep. 60: 343–346.
92. Yajnik, C.S., H.G. Lubree, N.V. Thuse, et al. 2007. Oral vitamin B12 supplementation reduces plasma total homocysteine concentration in women in India. Asia Pac. J. Clin. Nutr. 16: 103–109.
93. Yajnik, C.S., S.S. Deshpande, A.V. Panchanadikar, et al. 2005. Maternal total homocysteine concentration and neonatal size in India. Asia Pac. J. Clin. Nutr. 14: 179–181.
94. Jiang, T., P. Christian, S.K. Khatry, et al. 2005. Micronutrient deficiencies in early pregnancy are common, concurrent, and vary by season among rural Nepali pregnant women. J. Nutr. 135: 1106–1112.
95. Kapil, U. & A.S. Bhadoria. 2014. Prevalence of folate, ferritin and cobalamin deficiencies amongst adolescent in India. J. Family Med. Prim. Care 3: 247–249.
96. Godbole, K., U. Deshmukh & C. Yajnik. 2009. Nutrigenetic determinants of neural tube defects in India. Indian Pediatr. 46: 467–475.
97. Neumann, C.G., S.M. Oace, M.P. Chaparro, et al. 2013. Low vitamin B12 intake during pregnancy and lactation and low breastmilk vitamin 12 content in rural Kenyan women consuming predominantly maize diets. Food Nutr. Bull. 34: 151–159.
98. Shahab-Ferdows, S., R. Engle-Stone, D. Hampel, et al. 2015. Regional, socioeconomic, and dietary risk factors for vitamin B-12 deficiency differ from those for folate deficiency in Cameroonian women and children. J. Nutr. 145: 2587–2595.
99. Wirth, J.P., F. Rohner, B.A. Woodruff, et al. 2016. Anemia, micronutrient deficiencies, and malaria in children and women in Sierra Leone prior to the Ebola outbreak—findings of a cross-sectional study. PLoS One 11: e0155031.
100. Harvey-Leeson, S., C.D. Karakochuk, M. Hawes, et al. 2016. Anemia and micronutrient status of women of childbearing age and children 6–59 months in the Democratic Republic of the Congo. Nutrients 8: 98.
101. Dei-Adomakoh, Y., J.K. Acquaye, I. Ekem, et al. 2014. Second trimester anaemia in pregnant Ghanaians. West Afr. J. Med. 33: 229–233.
102. Fernandes-Costa, F. & J. Metz. 1982. A comparison of serum transcobalamin levels in white and black subjects. Am. J. Clin. Nutr. 35: 83–86.
103. Fleming, A.F., Y.A. Ogunfunmilade & R. Carmel. 1978. Serum vitamin B12 levels and vitamin B12-binding proteins of serum and saliva of healthy Nigerians and Europeans. Am. J. Clin. Nutr. 31: 1732–1738.
104. Saxena, S. & R. Carmel. 1987. Racial differences in vitamin B12 levels in the United States. Am. J. Clin. Pathol. 88: 95–97.
105. Stabler, S.P., R.H. Allen, L.P. Fried, et al. 1999. Racial differences in prevalence of cobalamin and folate deficiencies in disabled elderly women. Am. J. Clin. Nutr. 70: 911–919.
106. Pfeiffer, C.M., C.L. Johnson, R.B. Jain, et al. 2007. Trends in blood folate and vitamin B-12 concentrations in the United States, 1988–2004. Am. J. Clin. Nutr. 86: 718–727.
107. Oussalah, A., C. Besseau, C. Chery, et al. 2012. Helicobacter pylori serologic status has no influence on the association between fucosyltransferase 2 polymorphism (FUT2 461 G→A) and vitamin B-12 in Europe and West Africa. Am. J. Clin. Nutr. 95: 514–521.
108. Kelly, R.J., S. Rouquier, D. Giorgi, et al. 1995. Sequence and expression of a candidate for the human Secretor blood group alpha(1,2)fucosyltransferase gene (FUT2). Homozygosity for an enzyme-inactivating nonsense mutation commonly correlates with the non-secretor phenotype. J. Biol. Chem. 270: 4640–4649.
109. Marionneau, S., A. Cailleau-Thomas, J. Rocher, et al. 2001. ABH and Lewis histo-blood group antigens, a model for the meaning of oligosaccharide diversity in the face of a changing world. Biochimie 83: 565–573.
110. Segurel, L., E.E. Thompson, T. Flutre, et al. 2012. The ABO blood group is a trans-species polymorphism in primates. Proc. Natl. Acad. Sci. USA 109: 18493–18498.
111. Molloy, A.M., J.L. Mills, P.N. Kirke, et al. 1998. Low blood folates in NTD pregnancies are only partly explained by thermolabile 5,10-methylenetetrahydrofolate reductase: low folate status alone may be the critical factor. Am. J. Med. Genet. 78: 155–159.
112. Molloy, A.M., S. Daly, J.L. Mills, et al. 1997. Thermolabile variant of 5,10-methylenetetrahydrofolate reductase associated with low red-cell folates: implications for folate intake recommendations. Lancet 349: 1591–1593.
113. Yang, Q.H., L.D. Botto, M. Gallagher, et al. 2008. Prevalence and effects of gene–gene and gene–nutrient interactions on serum folate and serum total homocysteine concentrations in the United States: findings from the third National Health and Nutrition Examination Survey DNA Bank. Am. J. Clin. Nutr. 88: 232–246.
114. Wilcken, B., F. Bamforth, Z. Li, et al. 2003. Geographical and ethnic variation of the 677C>T allele of 5,10 methylenetetrahydrofolate reductase (MTHFR): findings from over 7000 newborns from 16 areas world wide. J. Med. Genet. 40: 619–625.
115. Botto, L.D. & Q. Yang. 2000. 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. Am. J. Epidemiol. 151: 862–877.
116. Mutchinick, O.M., M.A. Lopez, L. Luna, et al. 1999. High prevalence of the thermolabile methylenetetrahydrofolate reductase variant in Mexico: a country with a very high prevalence of neural tube defects. Mol. Genet. Metab. 68: 461–467.
117. Crider, K.S., J.H. Zhu, L. Hao, et al. 2011. MTHFR 677C→T genotype is associated with folate and homocysteine concentrations in a large, population-based, double-blind trial of folic acid supplementation. Am. J. Clin. Nutr. 93: 1365–1372.
118. Williams, L.J., S.A. Rasmussen, A. Flores, et al. 2005. Decline in the prevalence of spina bifida and anencephaly by race/ethnicity: 1995–2002. Pediatrics 116: 580–586.
119. Zaganjor, I., A. Sekkarie, B.L. Tsang, et al. 2016. Describing the prevalence of neural tube defects worldwide: a systematic literature review. PLoS One 11: e0151586.
120. Besser, L.M., L.J. Williams & J.D. Cragan. 2007. Interpreting changes in the epidemiology of anencephaly and spina bifida following folic acid fortification of the U.S. grain supply in the setting of long-term trends, Atlanta, Georgia, 1968–2003. Birth Defects Res. A Clin. Mol. Teratol. 79: 730–736.
121. Shah, T., K. Joshi, S. Mishra, et al. 2016. Molecular and cellular effects of vitamin B12 forms on human trophoblast cells in presence of excessive folate. Biomed. Pharmacother. 84: 526–534.
122. Katre, P., D. Bhat, H. Lubree, et al. 2010. Vitamin B12 and folic acid supplementation and plasma total homocysteine concentrations in pregnant Indian women with low B12 and high folate status. Asia Pac. J. Clin. Nutr. 19: 335–343.
123. Yajnik, C.S., S.S. Deshpande, A.A. Jackson, et al. 2008. Vitamin B12 and folate concentrations during pregnancy and insulin resistance in the offspring: the Pune Maternal Nutrition Study. Diabetologia 51: 29–38.
124. Carmel, R. 2011. Mandatory fortification of the food supply with cobalamin: an idea whose time has not yet come. J. Inherit. Metab. Dis. 34: 67–73.
125. Refsum, H. & A.D. Smith. 2008. Are we ready for mandatory fortification with vitamin B-12? Am. J. Clin. Nutr. 88: 253–254.
126. Carmel, R. 2008. Efficacy and safety of fortification and supplementation with vitamin B12: biochemical and physiological effects. Food Nutr. Bull. 29: S177–S187.
127. Chanarin, I. 1969. The Megaloblastic Anaemias. Oxford and Edinburgh: Blackwell Scientific Publications.
128. Bor, M.V., E. Lydeking-Olsen, J. Moller, et al. 2006. A daily intake of approximately 6 microg vitamin B-12 appears to saturate all the vitamin B-12-related variables in Danish postmenopausal women. Am. J. Clin. Nutr. 83: 52–58.
129. Abdeen, Z., A. Ramlawi, R. Qaswari, et al. 2015. Predicted efficacy of the Palestinian wheat flour fortification programme: complementary analysis of biochemical and dietary data. Public Health Nutr. 18: 1358–1368.
130. Dullemeijer, C., O.W. Souverein, E.L. Doets, et al. 2013. Systematic review with dose–response meta-analyses between vitamin B-12 intake and European Micronutrient Recommendations Aligned's prioritized biomarkers of vitamin B-12 including randomized controlled trials and observational studies in adults and elderly persons. Am. J. Clin. Nutr. 97: 390–402.
131. Dangour, A.D., E. Allen, R. Clarke, et al. 2011. A randomised controlled trial investigating the effect of vitamin B12 supplementation on neurological function in healthy older people: the Older People and Enhanced Neurological function (OPEN) study protocol [ISRCTN54195799]. Nutr. J. 10: 22.
132. Hill, M.H., J.E. Flatley, M.E. Barker, et al. 2013. A vitamin B-12 supplement of 500 μg/d for eight weeks does not normalize urinary methylmalonic acid or other biomarkers of vitamin B-12 status in elderly people with moderately poor vitamin B-12 status. J. Nutr. 143: 142–147.
133. Deshmukh, U.S., C.V. Joglekar, H.G. Lubree, et al. 2010. Effect of physiological doses of oral vitamin B12 on plasma homocysteine: a randomized, placebo-controlled, double-blind trial in India. Eur. J. Clin. Nutr. 64: 495–502.
134. Eussen, S.J., L.C. de Groot, R. Clarke, et al. 2005. Oral cyanocobalamin supplementation in older people with vitamin B12 deficiency: a dose-finding trial. Arch. Intern. Med. 165: 1167–1172.
135. Allen, L.H., I.H. Rosenberg, G.P. Oakley, et al. 2010. Considering the case for vitamin B12 fortification of flour. Food Nutr. Bull. 31: S36–S46.
136. Taneja, S., T.A. Strand, T. Kumar, et al. 2013. Folic acid and vitamin B-12 supplementation and common infections in 6–30-mo-old children in India: a randomized placebo-controlled trial. Am. J. Clin. Nutr. 98: 731–737.
137. Bae, S., A.A. West, J. Yan, et al. 2015. Vitamin B-12 status differs among pregnant, lactating, and control women with equivalent nutrient intakes. J. Nutr. 145: 1507–1514.
138. Duggan, C., K. Srinivasan, T. Thomas, et al. 2014. Vitamin B-12 supplementation during pregnancy and early lactation increases maternal, breast milk, and infant measures of vitamin B-12 status. J. Nutr. 144: 758–764.
139. Institute of Medicine Standing Committee on the Scientific Evaluation of Dietary Reference, I., O.B.V. its Panel on Folate & Choline. 1998. The National Academies Collection: reports funded by National Institutes of Health. In Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline. Washington, DC: National Academies Press (US), National Academy of Sciences.
140. Carmel, R. 2008. How I treat cobalamin (vitamin B12) deficiency. Blood 112: 2214–2221.
141. Allen, R.H. & S.P. Stabler. 2008. Identification and quantitation of cobalamin and cobalamin analogues in human feces. Am. J. Clin. Nutr. 87: 1324–1335.
142. Anonymous. 1976. Pathogenesis of the tapeworm anaemia. Br. Med. J. 2: 1028.